Back to Search
DAVID BODKIN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1134280605IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
G62107(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Class of 1984
Research & Publications (5)
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
PMID 19633475·J Thorac Oncol·2009
3-trial
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.
PMID 19332730·J Clin Oncol·2009
3-trial
Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
PMID 18089875·J Clin Oncol·2007
3-trial
Efficacy and safety of paclitaxel poliglumex as first-line chemotherapy in patients at high risk with advanced-stage non-small-cell lung cancer: results of a phase II study.
PMID 16354318·Clin Lung Cancer·2005
3-trial
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.
PMID 10955784·Clin Cancer Res·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5555 GROSSMONT CENTER DR
LA MESA, CA 91942 - Phone
- (619) 644-3030
Quick Facts
- NPI
- 1134280605
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 5
Are you this provider?
Claim Your Profile